Invex Therapeutics Ltd. (AU:IXC) has released an update.
Invex Therapeutics Ltd. reported a significant reduction in losses after tax, down 79% from the previous year, and a 37% increase in other income. No dividends will be proposed and the company’s net tangible assets per share have decreased to 2.18 cents. An upcoming virtual Annual General Meeting is scheduled for November 26, 2024.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.
